Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial

Christian Iorio-MorinDavid Mathieu


Chronic subdural hematoma (CSDH) is one of the most frequent reason for cranial neurosurgical consultation. There is no widely accepted medical treatment for this condition. Herein, we present the protocol for the Tranexamic Acid (TXA) in Chronic Subdural Hematomas (TRACS) trial aiming at determining whether TXA can increase the rate of CSDH resolution following conservative management, lower the number of required surgical procedures and decrease the rate of CSDH recurrence following surgical evacuation. TRACS is a multicenter, double-blind, randomized, parallel-design, placebo-controlled, phase IIB study designed to provide preliminary efficacy data as well as feasibility, safety and incidence data required to plan a larger definitive phase III trial. Consecutive patients presenting with a diagnosis of chronic subdural hematoma will be screened for eligibility. Exclusion criteria include: specific risk factors for thromboembolic disease, anticoagulant use or contraindication to TXA. A total of 130 patients will be randomized to receive either 750 mg of TXA daily or placebo until complete radiological resolution of the CSDH or for a maximum of 20 weeks. CSDH volume will be measured on serial computed tomography (CT) scanning. ...Continue Reading

Associated Clinical Trials


Jan 1, 1989·Journal of Clinical Epidemiology·S ShahB Cooper
Dec 23, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·B Vujkovac, M Sabovic
Jun 27, 2003·Drugs·Keri Wellington, Antona J Wagstaff
Apr 27, 2010·Anesthesia and Analgesia·Jerrold H LevyJohn Roback
Mar 18, 2011·The Cochrane Database of Systematic Reviews·David A HenryKatharine Ker
Mar 25, 2011·Journal of Korean Neurosurgical Society·Hyuck-Jin OhHack-Gun Bae
May 23, 2012·BMJ : British Medical Journal·Katharine KerIan Roberts
May 7, 2013·Journal of Neurosurgery·Hiroshi KageyamaKazunari Oka
Jun 6, 2013·Canadian Geriatrics Journal : CGJ·Zahinoor IsmailKen Shulman
Aug 9, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Nancy J Devlin, Paul F M Krabbe
Oct 22, 2013·JAMA : the Journal of the American Medical Association·UNKNOWN World Medical Association

❮ Previous
Next ❯


Dec 3, 2016·Journal of the International Association of Providers of AIDS Care·Raja K KuttyM Anilkumar
Aug 4, 2018·Journal of Neurotrauma·Christian Iorio-MorinDavid Mathieu
Jan 7, 2018·Neurocritical Care·Eelco F M Wijdicks
Jan 26, 2018·Medizinische Klinik, Intensivmedizin und Notfallmedizin·J WaskowskiF Stueber
Mar 6, 2019·Journal of Neurosurgery·Ambuj Kumar, Yad Ram Yadav
Feb 7, 2020·Acta neurochirurgica·E EdlmannUNKNOWN International Collaborative Research Initiative on Chronic Subdural Haematoma (iCORIC) study group
Jun 25, 2018·Current Treatment Options in Neurology·Elena I FomchenkoKevin N Sheth
Jun 1, 2017·Journal of Neuroinflammation·Ellie EdlmannPeter J Hutchinson
Jan 29, 2021·Complementary Therapies in Clinical Practice·Seungwon KwonKi-Ho Cho
May 18, 2018·World Neurosurgery·Dana C HollUNKNOWN Dutch Chronic Subdural Hematoma Research Group (DSHR)

❮ Previous
Next ❯

Clinical Trials Mentioned


Software Mentioned


Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.